Citation

EN CN
Scientist.com
Approved Supplier
×

Subscribe Us

By subscription, you consent to allow Ubigene Biosciences to store and process the information provided above to deliver the latest news, research spotlight, and promotions. You can unsubscribe from these communications at anytime.
ENCN
location： Home > Citation >

Contact us✖

If we are unable to reach you via email, how else can we contact you?

Citation

Engineered
Cell Line Engineered Microbe Plasmid/Virus Products CRISPR Library
All Luc/EGFP cells Cas9 cells Wild-type cells Kit Culture medium Cas9 protein
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
Author: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
DOI: 10.1016/j.cell.2024.12.010
Related Service or Product: Culture Medium
Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc
IF=20.8
Nature Metabolism
Author: Juhong Wang, Yannan Yang, Fei Shao, Ying Meng, Dong Guo, Jie He & Zhimin Lu
DOI: 10.1038/s42255-024-01037-4
Related Service or Product: Point Mutation Cas9 Stable Cell Lines
Interpretation >
Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery
IF=19.8
Cell Stem Cell
Author: Zihang Pan, ∙ Qiyang Yao, ∙ Weijing Kong ∙ Xiaojing Ma ∙ Liangliang Tian ∙ Yun Zhao ∙ Shuntian Zhu ∙ Sheng Chen ∙ Mengze Sun ∙ Jiao Liu ∙ Simin Jiang ∙ Jianxun Ma ∙ Qijia Liu ∙ Xiaohong Peng ∙ Xiaoxia Li ∙ Zixuan Hong ∙ Yi Hong ∙ Xue Wang ∙ Jiarui Liu ∙ Jingjing Zhang ∙ Wei Zhang ∙ Bingbing Sun ∙ Sara Pahlavan ∙ Youchen Xia ∙ Weimin Shen ∙ Yuyong Liu ∙ Wenjian Jiang ∙ Zhengwei Xie ∙ Wei Kong∙ Xi Wang,, ∙ Kai Wang,
DOI: 10.1016/j.stem.2024.10.015
Related Service or Product: Luciferase Stable Cell Lines
Intelligent Nano‐Cage for Precision Delivery of CRISPR‐Cas9 and ACC Inhibitors to Enhance Antitumor Cascade Therapy Through Lipid Metabolism Disruption
IF=18.5
Advanced Functional Materials
Author: Wei Zhao, La Zhang, Jiao Guo, Qing Xu, Mi Zhang, Hongqing Liu, Cong Ren, Yifan Zhao, Jianwei Wang, Qiling Peng, Ning Jiang
DOI: 10.1002/adfm.202418090
Related Service or Product: Cas9 Stable Cell Lines
Adaptive Design of Nanovesicles Overcoming Immunotherapeutic Limitations of Chemotherapeutic Drugs through Poliovirus Receptor Blockade.
IF=17.1
ACS nano
Author: Yongkang Yu, Fan Zhang, Wenqing Xiao, Qinzhen Cheng, Tingxuan Li, Jing Tang, Wei Tao, Lin Mei
DOI: 10.1021/acsnano.3c13056
Related Service or Product: Luciferase Stable Cell Lines
Interpretation >
Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition
IF=16.6
Nature Communications
Author: Minglu Zhou, Chendong Liu, Bo Li, Junlin Li, Ping Zhang, Yuan Huang & Lian Li
DOI: 10.1038/s41467-024-47111-z
Related Service or Product: Luciferase Stable Cell Lines
Interpretation >

Citation

Engineered Cell Line
All CRISPR gene editing Overexpression Interference
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
Author: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
DOI: 10.1016/j.cell.2024.12.010
Related Service or Product: Culture Medium
Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc
IF=20.8
Nature Metabolism
Author: Juhong Wang, Yannan Yang, Fei Shao, Ying Meng, Dong Guo, Jie He & Zhimin Lu
DOI: 10.1038/s42255-024-01037-4
Related Service or Product: Cas9 Stable Cell Lines
Interpretation >
Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery
IF=19.8
Cell Stem Cell
Author: Zihang Pan, ∙ Qiyang Yao, ∙ Weijing Kong ∙ Xiaojing Ma ∙ Liangliang Tian ∙ Yun Zhao ∙ Shuntian Zhu ∙ Sheng Chen ∙ Mengze Sun ∙ Jiao Liu ∙ Simin Jiang ∙ Jianxun Ma ∙ Qijia Liu ∙ Xiaohong Peng ∙ Xiaoxia Li ∙ Zixuan Hong ∙ Yi Hong ∙ Xue Wang ∙ Jiarui Liu ∙ Jingjing Zhang ∙ Wei Zhang ∙ Bingbing Sun ∙ Sara Pahlavan ∙ Youchen Xia ∙ Weimin Shen ∙ Yuyong Liu ∙ Wenjian Jiang ∙ Zhengwei Xie ∙ Wei Kong∙ Xi Wang,, ∙ Kai Wang,
DOI: 10.1016/j.stem.2024.10.015
Related Service or Product: Luciferase Stable Cell Lines
Intelligent Nano‐Cage for Precision Delivery of CRISPR‐Cas9 and ACC Inhibitors to Enhance Antitumor Cascade Therapy Through Lipid Metabolism Disruption
IF=18.5
Advanced Functional Materials
Author: Wei Zhao, La Zhang, Jiao Guo, Qing Xu, Mi Zhang, Hongqing Liu, Cong Ren, Yifan Zhao, Jianwei Wang, Qiling Peng, Ning Jiang
DOI: 10.1002/adfm.202418090
Related Service or Product: Cas9 Stable Cell Lines
Adaptive Design of Nanovesicles Overcoming Immunotherapeutic Limitations of Chemotherapeutic Drugs through Poliovirus Receptor Blockade.
IF=17.1
ACS nano
Author: Yongkang Yu, Fan Zhang, Wenqing Xiao, Qinzhen Cheng, Tingxuan Li, Jing Tang, Wei Tao, Lin Mei
DOI: 10.1021/acsnano.3c13056
Related Service or Product: Luciferase Stable Cell Lines
Interpretation >
Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition
IF=16.6
Nature Communications
Author: Minglu Zhou, Chendong Liu, Bo Li, Junlin Li, Ping Zhang, Yuan Huang & Lian Li
DOI: 10.1038/s41467-024-47111-z
Related Service or Product: Luciferase Stable Cell Lines
Interpretation >
Engineered Microbe
All Escherichia coli Salmonella Pseudomonas aeruginosa Staphylococcus aureus
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
Author: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
DOI: 10.1016/j.cell.2024.12.010
Related Service or Product: Culture Medium
Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc
IF=20.8
Nature Metabolism
Author: Juhong Wang, Yannan Yang, Fei Shao, Ying Meng, Dong Guo, Jie He & Zhimin Lu
DOI: 10.1038/s42255-024-01037-4
Related Service or Product: Cas9 Stable Cell Lines
Interpretation >
Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery
IF=19.8
Cell Stem Cell
Author: Zihang Pan, ∙ Qiyang Yao, ∙ Weijing Kong ∙ Xiaojing Ma ∙ Liangliang Tian ∙ Yun Zhao ∙ Shuntian Zhu ∙ Sheng Chen ∙ Mengze Sun ∙ Jiao Liu ∙ Simin Jiang ∙ Jianxun Ma ∙ Qijia Liu ∙ Xiaohong Peng ∙ Xiaoxia Li ∙ Zixuan Hong ∙ Yi Hong ∙ Xue Wang ∙ Jiarui Liu ∙ Jingjing Zhang ∙ Wei Zhang ∙ Bingbing Sun ∙ Sara Pahlavan ∙ Youchen Xia ∙ Weimin Shen ∙ Yuyong Liu ∙ Wenjian Jiang ∙ Zhengwei Xie ∙ Wei Kong∙ Xi Wang,, ∙ Kai Wang,
DOI: 10.1016/j.stem.2024.10.015
Related Service or Product: Luciferase Stable Cell Lines
Intelligent Nano‐Cage for Precision Delivery of CRISPR‐Cas9 and ACC Inhibitors to Enhance Antitumor Cascade Therapy Through Lipid Metabolism Disruption
IF=18.5
Advanced Functional Materials
Author: Wei Zhao, La Zhang, Jiao Guo, Qing Xu, Mi Zhang, Hongqing Liu, Cong Ren, Yifan Zhao, Jianwei Wang, Qiling Peng, Ning Jiang
DOI: 10.1002/adfm.202418090
Related Service or Product: Cas9 Stable Cell Lines
Adaptive Design of Nanovesicles Overcoming Immunotherapeutic Limitations of Chemotherapeutic Drugs through Poliovirus Receptor Blockade.
IF=17.1
ACS nano
Author: Yongkang Yu, Fan Zhang, Wenqing Xiao, Qinzhen Cheng, Tingxuan Li, Jing Tang, Wei Tao, Lin Mei
DOI: 10.1021/acsnano.3c13056
Related Service or Product: Luciferase Stable Cell Lines
Interpretation >
Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition
IF=16.6
Nature Communications
Author: Minglu Zhou, Chendong Liu, Bo Li, Junlin Li, Ping Zhang, Yuan Huang & Lian Li
DOI: 10.1038/s41467-024-47111-z
Related Service or Product: Luciferase Stable Cell Lines
Interpretation >
Plasmid/Virus
All Knockout Overexpression Interference Knock in/Point mutation lentivirus Adeno-associated virus Adenovirus
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
Author: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
DOI: 10.1016/j.cell.2024.12.010
Related Service or Product: Culture Medium
Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc
IF=20.8
Nature Metabolism
Author: Juhong Wang, Yannan Yang, Fei Shao, Ying Meng, Dong Guo, Jie He & Zhimin Lu
DOI: 10.1038/s42255-024-01037-4
Related Service or Product: Cas9 Stable Cell Lines
Interpretation >
Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery
IF=19.8
Cell Stem Cell
Author: Zihang Pan, ∙ Qiyang Yao, ∙ Weijing Kong ∙ Xiaojing Ma ∙ Liangliang Tian ∙ Yun Zhao ∙ Shuntian Zhu ∙ Sheng Chen ∙ Mengze Sun ∙ Jiao Liu ∙ Simin Jiang ∙ Jianxun Ma ∙ Qijia Liu ∙ Xiaohong Peng ∙ Xiaoxia Li ∙ Zixuan Hong ∙ Yi Hong ∙ Xue Wang ∙ Jiarui Liu ∙ Jingjing Zhang ∙ Wei Zhang ∙ Bingbing Sun ∙ Sara Pahlavan ∙ Youchen Xia ∙ Weimin Shen ∙ Yuyong Liu ∙ Wenjian Jiang ∙ Zhengwei Xie ∙ Wei Kong∙ Xi Wang,, ∙ Kai Wang,
DOI: 10.1016/j.stem.2024.10.015
Related Service or Product: Luciferase Stable Cell Lines
Intelligent Nano‐Cage for Precision Delivery of CRISPR‐Cas9 and ACC Inhibitors to Enhance Antitumor Cascade Therapy Through Lipid Metabolism Disruption
IF=18.5
Advanced Functional Materials
Author: Wei Zhao, La Zhang, Jiao Guo, Qing Xu, Mi Zhang, Hongqing Liu, Cong Ren, Yifan Zhao, Jianwei Wang, Qiling Peng, Ning Jiang
DOI: 10.1002/adfm.202418090
Related Service or Product: Cas9 Stable Cell Lines
Adaptive Design of Nanovesicles Overcoming Immunotherapeutic Limitations of Chemotherapeutic Drugs through Poliovirus Receptor Blockade.
IF=17.1
ACS nano
Author: Yongkang Yu, Fan Zhang, Wenqing Xiao, Qinzhen Cheng, Tingxuan Li, Jing Tang, Wei Tao, Lin Mei
DOI: 10.1021/acsnano.3c13056
Related Service or Product: Luciferase Stable Cell Lines
Interpretation >
Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition
IF=16.6
Nature Communications
Author: Minglu Zhou, Chendong Liu, Bo Li, Junlin Li, Ping Zhang, Yuan Huang & Lian Li
DOI: 10.1038/s41467-024-47111-z
Related Service or Product: Luciferase Stable Cell Lines
Interpretation >
Products
All Luc/EGFP cells Cas9 cells Wild-type cells Kit Culture medium Cas9 protein
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
Author: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
DOI: 10.1016/j.cell.2024.12.010
Related Service or Product: Culture Medium
Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc
IF=20.8
Nature Metabolism
Author: Juhong Wang, Yannan Yang, Fei Shao, Ying Meng, Dong Guo, Jie He & Zhimin Lu
DOI: 10.1038/s42255-024-01037-4
Related Service or Product: Cas9 Stable Cell Lines
Interpretation >
Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery
IF=19.8
Cell Stem Cell
Author: Zihang Pan, ∙ Qiyang Yao, ∙ Weijing Kong ∙ Xiaojing Ma ∙ Liangliang Tian ∙ Yun Zhao ∙ Shuntian Zhu ∙ Sheng Chen ∙ Mengze Sun ∙ Jiao Liu ∙ Simin Jiang ∙ Jianxun Ma ∙ Qijia Liu ∙ Xiaohong Peng ∙ Xiaoxia Li ∙ Zixuan Hong ∙ Yi Hong ∙ Xue Wang ∙ Jiarui Liu ∙ Jingjing Zhang ∙ Wei Zhang ∙ Bingbing Sun ∙ Sara Pahlavan ∙ Youchen Xia ∙ Weimin Shen ∙ Yuyong Liu ∙ Wenjian Jiang ∙ Zhengwei Xie ∙ Wei Kong∙ Xi Wang,, ∙ Kai Wang,
DOI: 10.1016/j.stem.2024.10.015
Related Service or Product: Luciferase Stable Cell Lines
Intelligent Nano‐Cage for Precision Delivery of CRISPR‐Cas9 and ACC Inhibitors to Enhance Antitumor Cascade Therapy Through Lipid Metabolism Disruption
IF=18.5
Advanced Functional Materials
Author: Wei Zhao, La Zhang, Jiao Guo, Qing Xu, Mi Zhang, Hongqing Liu, Cong Ren, Yifan Zhao, Jianwei Wang, Qiling Peng, Ning Jiang
DOI: 10.1002/adfm.202418090
Related Service or Product: Cas9 Stable Cell Lines
Adaptive Design of Nanovesicles Overcoming Immunotherapeutic Limitations of Chemotherapeutic Drugs through Poliovirus Receptor Blockade.
IF=17.1
ACS nano
Author: Yongkang Yu, Fan Zhang, Wenqing Xiao, Qinzhen Cheng, Tingxuan Li, Jing Tang, Wei Tao, Lin Mei
DOI: 10.1021/acsnano.3c13056
Related Service or Product: Luciferase Stable Cell Lines
Interpretation >
Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition
IF=16.6
Nature Communications
Author: Minglu Zhou, Chendong Liu, Bo Li, Junlin Li, Ping Zhang, Yuan Huang & Lian Li
DOI: 10.1038/s41467-024-47111-z
Related Service or Product: Luciferase Stable Cell Lines
Interpretation >
CRISPR Library
All
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
IF=45.5
Cell
Author: Liping Zhong1,13 ∙ Lu Gan1,13 ∙ Bing Wang2,13 ∙ Tao Wu3,13 ∙ Fei Yao4 ∙ Wenlin Gong1 ∙ Hongmei Peng3 ∙ Zhiming Deng3 ∙ Guoyou Xiao5 ∙ Xiyu Liu1 ∙ Jintong Na1 ∙ Desong Xia1 ∙ Xianjun Yu6 ∙ Zhikun Zhang1 ∙ Bangde Xiang7 ∙ Yu Huo1 ∙ Dan Yan4 ∙ Zhixin Dong4 ∙ Fang Fang4 ∙ Yun Ma8 ∙ Guanqiao Jin9 ∙ Danke Su9 ∙ Xiuli Liu1 ∙ Qiang Li9 ∙ Hai Liao9 ∙ Chao Tang1 ∙ Jian He1 ∙ Zhiping Tang10 ∙ Shilai Zhang5 ∙ Bingqing Qiu5 ∙ Zhi Yang5 ∙ Lihui Yang11 ∙ Ziqin Chen3 ∙ Mengsi Zeng3 ∙ Ronghua Feng3 ∙ Jiege Jiao12 ∙ Yuan Liao1 ∙ Tinghua Wang1 ∙ Liangliang Wu1 ∙ Zhengcheng Mi1 ∙ Ziqun Liu2 ∙ Si Shi6 ∙ Kun Zhang1 ∙ Wei Shi4 ∙ Yongxiang Zhao
DOI: 10.1016/j.cell.2024.12.010
Related Service or Product: Culture Medium
Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc
IF=20.8
Nature Metabolism
Author: Juhong Wang, Yannan Yang, Fei Shao, Ying Meng, Dong Guo, Jie He & Zhimin Lu
DOI: 10.1038/s42255-024-01037-4
Related Service or Product: Point Mutation Cas9 Stable Cell Lines
Interpretation >
Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery
IF=19.8
Cell Stem Cell
Author: Zihang Pan, ∙ Qiyang Yao, ∙ Weijing Kong ∙ Xiaojing Ma ∙ Liangliang Tian ∙ Yun Zhao ∙ Shuntian Zhu ∙ Sheng Chen ∙ Mengze Sun ∙ Jiao Liu ∙ Simin Jiang ∙ Jianxun Ma ∙ Qijia Liu ∙ Xiaohong Peng ∙ Xiaoxia Li ∙ Zixuan Hong ∙ Yi Hong ∙ Xue Wang ∙ Jiarui Liu ∙ Jingjing Zhang ∙ Wei Zhang ∙ Bingbing Sun ∙ Sara Pahlavan ∙ Youchen Xia ∙ Weimin Shen ∙ Yuyong Liu ∙ Wenjian Jiang ∙ Zhengwei Xie ∙ Wei Kong∙ Xi Wang,, ∙ Kai Wang,
DOI: 10.1016/j.stem.2024.10.015
Related Service or Product: Luciferase Stable Cell Lines
Intelligent Nano‐Cage for Precision Delivery of CRISPR‐Cas9 and ACC Inhibitors to Enhance Antitumor Cascade Therapy Through Lipid Metabolism Disruption
IF=18.5
Advanced Functional Materials
Author: Wei Zhao, La Zhang, Jiao Guo, Qing Xu, Mi Zhang, Hongqing Liu, Cong Ren, Yifan Zhao, Jianwei Wang, Qiling Peng, Ning Jiang
DOI: 10.1002/adfm.202418090
Related Service or Product: Cas9 Stable Cell Lines
Adaptive Design of Nanovesicles Overcoming Immunotherapeutic Limitations of Chemotherapeutic Drugs through Poliovirus Receptor Blockade.
IF=17.1
ACS nano
Author: Yongkang Yu, Fan Zhang, Wenqing Xiao, Qinzhen Cheng, Tingxuan Li, Jing Tang, Wei Tao, Lin Mei
DOI: 10.1021/acsnano.3c13056
Related Service or Product: Luciferase Stable Cell Lines
Interpretation >
Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition
IF=16.6
Nature Communications
Author: Minglu Zhou, Chendong Liu, Bo Li, Junlin Li, Ping Zhang, Yuan Huang & Lian Li
DOI: 10.1038/s41467-024-47111-z
Related Service or Product: Luciferase Stable Cell Lines
Interpretation >

Contact us✖

If we are unable to reach you via email, how else can we contact you?

WhatsApp: +86 153 6067 3248
TEL: +86 153 6067 3248 (Int'l)
US Toll free: 855 777 3210
EU Toll free: 800 3272 9252
Korea Toll free: 001 800 3272 9252

Gene Editing Services

EZ-editor™ Products

Copyright © 2024 Ubigene. All rights reserved.
×

Search documentation

Literature:

Name: *

Company: *

Telephone: *

Email:

Notes: After submitting the order, we will contact you as soon as possible.

request now
Contact us
✖

Contact us

If we are unable to reach you via email, how else can we contact you?
✖
Submission Succeeded
Book A Virtual Meeting With Technical Support